Headlines
-
Evidence-based screening
Monday | Mar 27 2017THE Pharmaceutical Society of Australia (PSA) has come out of its corner in response to media reports criticising the Amcal "Strokecheck" screening service, saying that screening and "risk assessment activities in community pharmacy must be evidence-based, meet unmet needs in the community, be appropriate for a pharmacy setting and provided by an appropriately-trained pharmacist".
-
Sigma confirms forecast
Friday | Mar 24 2017SIGMA Pharmaceuticals ceo Mark Hooper yesterday reaffirmed that the company was expecting earnings growth of at least 5% this year, with the company recording $100.2m in underlying profit for the year to 31 Jan (PD breaking news).
-
PSNZ awards new Fellowships
Thursday | Mar 23 2017THE Pharmaceutical Society of New Zealand (PSNZ) has awarded three new Fellowships to "outstanding candidates who have made and continue to make an exceptional contribution to the profession".
-
Pharmacy key for flu vax
Thursday | Mar 23 2017ALMOST all Australians (93%)have identified pharmacy as the place to receive their influenza vaccine this season, citing access, cost and convenience as the biggest motivators, the Pharmacy Guild of Australia reports.
-
AFT seals NovoTears deal
Wednesday | Mar 22 2017AFT Pharmaceuticals yesterday confirmed a new licensing agreement with German specialty pharmaceutical company to distribute NovaTears in Australia and New Zealand.
-
Compounding feedback
Wednesday | Mar 22 2017THE Pharmaceutical Society of Australia is seeking submissions on its revised Compounding Standard, yesterday releasing a consultation paper which is open to feedback until 18 Apr 2017.
-
NatRUM alerts to med risks
Tuesday | Mar 21 2017JUST 18% of Australians are aware of the National Return and Disposal of Unwanted Medicines (NatRUM) scheme, with most people simply putting unused drugs into their household rubbish.
-
EpiPen auto-injector recall
Tuesday | Mar 21 2017ALPHAPHARM, in consultation with the Therapeutic Goods Administration (TGA), has announced it is recalling four batches of EpiPen 300 microgram adrenaline injection syringe auto-injectors, due to the potential failure to activate or the need to apply increased force to activate the device.
-
SHPA transparency call
Monday | Mar 20 2017THE Society of Hospital Pharmacists of Australia (SHPA) has supported the concept of full and open transparency on the part of the Therapeutic Goods Administration (TGA) in its submission to the TGA relating to 'Expedited pathways for prescription medicines'.
-
$30m Yasmin patent payout
Monday | Mar 20 2017BAYER will receive more than $30 million in damages and interest after receiving a favourable judgement in its long-running case with Generic Health over patent infringement for its Yasmin and YAZ oral contraceptives.